Bayer Global News Overview Bayer off to an excellent start in 2008 Interim report for the first quarter of 2008 Expanded Labeling for MabCampath® in Europe US Food and Drug Administration Approves RECOTHROM™ Bayer and Onyx Provide Update on Phase III Trial of Nexavar® in Patients with Non-Small Cell Lung Cancer Bayer HealthCare Affiliate MEDRAD Announces Completion of Subsequent Offering Period for Shares of Possis Medical. Merger to Be Completed Shortly World Hemophilia Day on April 17th Bayer donates €250,000 for patients with hemophilia and provides nearly 1 million international units of Kogenate® Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
Expanded Labeling for MabCampath® in Europe
US Food and Drug Administration Approves RECOTHROM™ Bayer and Onyx Provide Update on Phase III Trial of Nexavar® in Patients with Non-Small Cell Lung Cancer Bayer HealthCare Affiliate MEDRAD Announces Completion of Subsequent Offering Period for Shares of Possis Medical. Merger to Be Completed Shortly World Hemophilia Day on April 17th Bayer donates €250,000 for patients with hemophilia and provides nearly 1 million international units of Kogenate® Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
